A biotechnology firm developing novel biopharmaceuticals to regulate cell secretion.

Related StoriesHPV research partnership signed between Beckman Coulter and IncellDxInner hearing damage human brain warnings from nerve cellsJumping genes: a marker for early tumor medical diagnosis? An interview with Dr KazazianAGN-214868 was discovered under the collaboration using Syntaxin’s proprietary discovery platform. Under this contract, Allergan is responsible for the clinical development, sales and advertising of identified drug applicants. Syntaxin receives milestone payments and royalties on revenue. Dr Melanie Lee, CEO of Syntaxin, commented: ‘The progression of AGN-214868 into Stage II trials is an extremely important milestone for Syntaxin and validates the strength of our technology platform.Some of the therapies practiced by a naturopath consist of Mud therapies, hydro therapies, acupuncture etc.

Aging cells help to make old bodies Brown University biologists have uncovered intriguing evidence to support the theory that outdated cells help to make old bodies. In a scholarly research of baboons, scientists showed that as these pets age, the amount of aging cells within their skin significantly increases. Over time, cells lose their capability to divide, a continuing state referred to as replicative senescence. The new research, published in an advanced online edition of Research, is the first to quantify the current presence of replicatively senescent cells in virtually any species.